Amneal Pharmaceuticals (AMRX) Net Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 948.00 |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -990.00 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -1,504.00 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 675.00 |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 787.00 |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 427.00 |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -228,760.00 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -163.00 |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 17,272.00 |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | -7,485.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 675.00 |
| Mar 31, 2026 | 1,204.00 |
| Dec 31, 2025 | 680.00 |
| Sep 30, 2025 | 280.00 |
| Jun 30, 2025 | 2,651.00 |
| Mar 31, 2025 | 397.00 |
| Dec 31, 2024 | -165.00 |
| Sep 30, 2024 | 248.00 |
| Jun 30, 2024 | -32.00 |
| Mar 31, 2024 | -1,375.00 |
| Dec 31, 2023 | -1,539.00 |
| Sep 30, 2023 | 329.00 |
| Jun 30, 2023 | 457.00 |
| Mar 31, 2023 | -2,433.00 |
| Dec 31, 2022 | 738.00 |
| Sep 30, 2022 | 6,956.00 |
| Jun 30, 2022 | -1,742.00 |
| Mar 31, 2022 | 1,030.00 |
| Dec 31, 2021 | 57.00 |
| Sep 30, 2021 | -226.00 |